Estimated small dense low-density lipoprotein-cholesterol and the risk of kidney and cardiovascular outcomes in diabetic kidney disease

References

• International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium: International Diabetes Federation; 2021.
   Google Scholar
• American Diabetes Association Professional Practice Committee. 11. Chronic kidney disease and risk management: standards of medical care in Diabetes—2022. Diabetes Care. 2022;45(Suppl. 1):S175–S184. doi: 10.2337/dc22-S011.
   PubMedGoogle Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2020;98(4S):S1–S115. doi: 10.1016/j.kint.2020.06.019.
   PubMedGoogle Scholar
• de Boer IH, Khunti K, Sadusky T, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2022;102(5):974–989. doi: 10.1016/j.kint.2022.08.012.
   PubMed Web of Science ®Google Scholar
• Thomas MC, Brownlee M, Susztak K, et al. Diabetic kidney disease. Nat Rev Dis Primers. 2015;1(1):15018. doi: 10.1038/nrdp.2015.18.
   PubMed Web of Science ®Google Scholar
• Pérez-López L, Boronat M, Melián C, et al. Animal models and renal biomarkers of diabetic nephropathy. In: Islam MdS, editor. Diabetes: from research to clinical practice. Advances in experimental medicine and biology. Vol. 1307. Cham: Springer International Publishing; 2020. p. 521–551. doi: 10.1007/5584_2020_527.
   Google Scholar
• Opazo-Ríos L, Mas S, Marín-Royo G, et al. Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. Int J Mol Sci. 2020;21(7):2632. doi: 10.3390/ijms21072632.
   PubMed Web of Science ®Google Scholar
• Thongnak L, Pongchaidecha A, Lungkaphin A. Renal lipid metabolism and lipotoxicity in diabetes. Am J Med Sci. 2020;359(2):84–99. doi: 10.1016/j.amjms.2019.11.004.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2019;73(24):e285–e350. doi: 10.1016/j.jacc.2018.11.003.
   PubMed Web of Science ®Google Scholar
• Superko HR, King S. Lipid management to reduce cardiovascular risk: a new strategy is required. Circulation. 2008;117(4):560–568; discussion 568. doi: 10.1161/CIRCULATIONAHA.106.667428.
   PubMed Web of Science ®Google Scholar
• Carmena R, Duriez P, Fruchart J-C. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 2004;109(23 Suppl. 1):III2–III7. doi: 10.1161/01.CIR.0000131511.50734.44.
   PubMed Web of Science ®Google Scholar
• Hoogeveen RC, Gaubatz JW, Sun W, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014;34(5):1069–1077. doi: 10.1161/ATVBAHA.114.303284.
   PubMed Web of Science ®Google Scholar
• Austin MA, Breslow JL, Hennekens CH, et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260(13):1917–1921. doi: 10.1001/jama.1988.03410130125037.
   PubMed Web of Science ®Google Scholar
• Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 276(11):875–881.
   PubMed Web of Science ®Google Scholar
• St-Pierre AC, Cantin B, Dagenais GR, et al. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol. 2005;25(3):553–559. doi: 10.1161/01.ATV.0000154144.73236.f4.
   PubMed Web of Science ®Google Scholar
• Higashioka M, Sakata S, Honda T, et al. Small dense low-density lipoprotein cholesterol and the risk of coronary heart disease in a Japanese community. J Atheroscler Thromb. 2020;27(7):669–682. doi: 10.5551/jat.51961.
   PubMed Web of Science ®Google Scholar
• Balling M, Nordestgaard BG, Langsted A, et al. Small dense low-density lipoprotein cholesterol predicts atherosclerotic cardiovascular disease in the Copenhagen General Population Study. J Am Coll Cardiol. 2020;75(22):2873–2875. doi: 10.1016/j.jacc.2020.03.072.
   PubMed Web of Science ®Google Scholar
• Filler G, Taheri S, McIntyre C, et al. Chronic kidney disease stage affects small, dense low-density lipoprotein but not glycated low-density lipoprotein in younger chronic kidney disease patients: a cross-sectional study. Clin Kidney J. 2018;11(3):383–388. doi: 10.1093/ckj/sfx115.
   PubMed Web of Science ®Google Scholar
• Shen H, Xu Y, Lu J, et al. Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients. BMC Nephrol. 2016;17(1):143. doi: 10.1186/s12882-016-0358-8.
   PubMed Web of Science ®Google Scholar
• Hung C-C, Tsai J-C, Kuo H-T, et al. Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials. Rev Diabet Stud. 2013;10(2–3):110–120. doi: 10.1900/RDS.2013.10.110.
   PubMedGoogle Scholar
• Sampson M, Wolska A, Warnick R, et al. A new equation based on the standard lipid panel for calculating small dense low-density lipoprotein-cholesterol and its use as a risk-enhancer test. Clin Chem. 2021;67(7):987–997. doi: 10.1093/clinchem/hvab048.
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Okada H, Hamaguchi M, et al. Estimated small dense low-density lipoprotein-cholesterol and incident type 2 diabetes in Japanese people: population-based Panasonic cohort study 13. Diabetes Res Clin Pract. 2023;199:110665. doi: 10.1016/j.diabres.2023.110665.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl. 1):S13–S27. doi: 10.2337/dc18-S002.
   PubMed Web of Science ®Google Scholar
• Tervaert TWC, Mooyaart AL, Amann K, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556–563. doi: 10.1681/ASN.2010010010.
   PubMed Web of Science ®Google Scholar
• NHANES – NCHS Research Ethics Review Board Approval [cited 2023 Jun 21]; 2023 [Online]. Available from: https://www.cdc.gov/nchs/nhanes/irba98.htm
   Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi: 10.7326/0003-4819-150-9-200905050-00006.
   PubMed Web of Science ®Google Scholar
• Kulkarni KR. Cholesterol profile measurement by vertical auto profile method. Clin Lab Med. 2006;26(4):787–802. doi: 10.1016/j.cll.2006.07.004.
   PubMed Web of Science ®Google Scholar
• Lindgren FT, Elliott HA, Gofman JW. The ultracentrifugal characterization and isolation of human blood lipids and lipoproteins, with applications to the study of atherosclerosis. J Phys Colloid Chem. 1951;55(1):80–93. doi: 10.1021/j150484a010.
   PubMedGoogle Scholar
• Williams PT, Zhao X-Q, Marcovina SM, et al. Levels of cholesterol in small LDL particles predict atherosclerosis progression and incident CHD in the HDL-Atherosclerosis Treatment Study (HATS). PLOS One. 2013;8(2):e56782. doi: 10.1371/journal.pone.0056782.
   PubMed Web of Science ®Google Scholar
• Ikezaki H, Lim E, Cupples LA, et al. Small dense low-density lipoprotein cholesterol is the most atherogenic lipoprotein parameter in the Prospective Framingham Offspring Study. J Am Heart Assoc. 2021;10(5):e019140. doi: 10.1161/JAHA.120.019140.
   PubMed Web of Science ®Google Scholar
• Sakai K, Koba S, Nakamura Y, et al. Small dense low-density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease. Geriatr Gerontol Int. 2018;18(6):965–972. doi: 10.1111/ggi.13287.
   PubMed Web of Science ®Google Scholar
• Huang H, Xie J, Hou L, et al. Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations. J Diabetes Investig. 2023;15(4):491–499. doi: 10.1111/jdi.14133.
   PubMed Web of Science ®Google Scholar
• Sorokin AV, Patel N, Li H, et al. Estimated sdLDL-C for predicting high-risk coronary plaque features in psoriasis: a prospective observational study. Lipids Health Dis. 2023;22(1):55. doi: 10.1186/s12944-023-01819-x.
   PubMed Web of Science ®Google Scholar
• Schaefer EJ, Ikezaki H, Diffenderfer MR, et al. Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: the pooling project. Atherosclerosis. 2023;367:15–23. doi: 10.1016/j.atherosclerosis.2023.01.015.
   PubMed Web of Science ®Google Scholar
• Hirano T, Satoh N, Kodera R, et al. Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: a cross-sectional study from a regional diabetes cohort. J Diabetes Investig. 2022;13(4):657–667. doi: 10.1111/jdi.13697.
   PubMed Web of Science ®Google Scholar
• Oi K, Hirano T, Sakai S, et al. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients. Kidney Int Suppl. 1999;71:S227–S228. doi: 10.1046/j.1523-1755.1999.07159.x.
   PubMedGoogle Scholar
• Farbakhsh K, Kasiske BL. Dyslipidemias in patients who have chronic kidney disease. Med Clin North Am. 2005;89(3):689–699. doi: 10.1016/j.mcna.2004.11.002.
   PubMed Web of Science ®Google Scholar
• Ivanova EA, Myasoedova VA, Melnichenko AA, et al. Small dense low-density lipoprotein as biomarker for atherosclerotic diseases. Oxid Med Cell Longev. 2017;2017:1273042. doi: 10.1155/2017/1273042.
   PubMed Web of Science ®Google Scholar
• Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002;43(9):1363–1379. doi: 10.1194/jlr.r200004-jlr200.
   PubMed Web of Science ®Google Scholar
• Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int. 1988;33(5):917–924. doi: 10.1038/ki.1988.87.
   PubMed Web of Science ®Google Scholar
• Zatz R, Meyer TW, Rennke HG, et al. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A. 1985;82(17):5963–5967. doi: 10.1073/pnas.82.17.5963.
   PubMed Web of Science ®Google Scholar
• Kasiske BL, O'Donnell MP, Schmitz PG, et al. Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int. 1990;37(3):880–891. doi: 10.1038/ki.1990.62.
   PubMed Web of Science ®Google Scholar
• Hattori M, Nikolic-Paterson DJ, Miyazaki K, et al. Mechanisms of glomerular macrophage infiltration in lipid-induced renal injury. Kidney Int Suppl. 1999;71:S47–S50. doi: 10.1046/j.1523-1755.1999.07112.x.
   PubMedGoogle Scholar
• Guijarro C, Kasiske BL, Kim Y, et al. Early glomerular changes in rats with dietary-induced hypercholesterolemia. Am J Kidney Dis. 1995;26(1):152–161. doi: 10.1016/0272-6386(95)90169-8.
   PubMed Web of Science ®Google Scholar
• Heeringa P, Tervaert JWC. Role of oxidized low-density lipoprotein in renal disease. Curr Opin Nephrol Hypertens. 2002;11(3):287–293. doi: 10.1097/00041552-200205000-00004.
   PubMed Web of Science ®Google Scholar
• Nosadini R, Tonolo G. Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes. Nutr Metab Cardiovasc Dis. 21(2):79–85.
   PubMed Web of Science ®Google Scholar
• Chen H-C, Guh J-Y, Shin S-J, et al. Pravastatin suppress superoxide and fibronectin production of glomerular mesangial cells induced by oxidized-LDL and high glucose. Atherosclerosis. 160(1):141–146.
   PubMed Web of Science ®Google Scholar